This is the annotated and expanded version of WEGO Health’s presentation at the FDA’s Public Hearing and the Health Activist Social Media Survey results with graphs and explanations.
Wego Health FDA Post Presentation Data Pptguest4c357f
Annotated and expanded version of WEGO Health’s presentation at the FDA’s Public Hearing and the Health Activist Social Media Survey results with graphs and explanations.
Patients Rising: How to Reach Empowered, Digital Health Consumerse-Patient Connections
Kru Research's white paper discussing how to reach out to empowered, digital, health consumers or e-Patients. Discussion of participatory medicine, digital health consumers, e-Patients, web 2.0, the power of social media, ROI of social media, regulatory concerns, HIPAA, FDA, adverse event reporting, and the future of social media in health marketing.
Social Media and Medicine: Fad or Shift?Gregg Masters
A social media tutorial for client medical group, including details on physician immersion in the broadly cast "digital health channel'. Some key trends in digital health, including both primary and secondary market research are recapped to suggest certain forward implications for a 'cloud based web presence'. Is social media a fad, I don't think empirical evidence would suggest such a conclusion.
Wego Health FDA Post Presentation Data Pptguest4c357f
Annotated and expanded version of WEGO Health’s presentation at the FDA’s Public Hearing and the Health Activist Social Media Survey results with graphs and explanations.
Patients Rising: How to Reach Empowered, Digital Health Consumerse-Patient Connections
Kru Research's white paper discussing how to reach out to empowered, digital, health consumers or e-Patients. Discussion of participatory medicine, digital health consumers, e-Patients, web 2.0, the power of social media, ROI of social media, regulatory concerns, HIPAA, FDA, adverse event reporting, and the future of social media in health marketing.
Social Media and Medicine: Fad or Shift?Gregg Masters
A social media tutorial for client medical group, including details on physician immersion in the broadly cast "digital health channel'. Some key trends in digital health, including both primary and secondary market research are recapped to suggest certain forward implications for a 'cloud based web presence'. Is social media a fad, I don't think empirical evidence would suggest such a conclusion.
Mounting interest in the field of mHealth—the provision of health-related services via mobile communica-tions—can be traced to the evolution of several interrelated trends. In many parts of the world, epidemicsand a shortage of healthcare workers continue to present grave challenges for governments and healthproviders. Yet in these same places, the explosive growth of mobile communications over the past decadeoffers a new hope for the promotion of quality healthcare. Among those who had previously been left behindby the ‘digital divide,’ billions now have access to reliable technology.There is a growing body of evidence that demonstrates the potential of mobile communications to radicallyimprove healthcare services—even in some of the most remote and resource-poor environments. This reportexamines issues at the heart of the rapidly evolving intersection of mobile phones and healthcare. It helps thereader to understand mHealth’s scope and implementation across developing regions, the health needs towhich mHealth can be applied, and the mHealth applications that promise the greatest impact on heath careinitiatives. It also examines building blocks required to make mHealth more widely available through sustain-able implementations. Finally, it calls for concerted action to help realize mHealth’s full potential.
April 2011 Study from WEGO Health focusing on how engaged and active Internet and social media users perceive pharma and health company use of the Internet
RememberItNow Presentation to U.S. Office of eHealth InitiativesMobile PRM
RememberItNow! recently presented their eHealth service to the U.S. Office of eHealth Initiatives in response to their request for information on new medication management technology.
Learn how RememberItNow! can improve medication compliance with SMS, Push and eMail medication reminders, an easy-to-use PHR, and a private care community.
Discover the future of eHealth and how it starts with the patient’s perspective. To learn more about RememberItNow! please visit:
http://www.rememberitnow.com
Healthcare Social Networking: Is Pharma Ready to Join the Conversation?Len Starnes
A pragmatic assessment of the impact of social networking on pharma marketing & sales. Includes analyses of HCPs' social networks, consumer/patient social networks and the convergence of PR with SEO and SEM. Presented at conferences in Zurich, Shanghai and Boston during 2008. This version presented at EyeforPharma's
E-Communications and Online Marketing Summit, Boston, 2008.
Just a year ago, Pew Internet & American Life Project report that nearly 113 million Americans were using the Internet to gather health-related information. It's not news that the Internet has become a magnet for people looking for quick answers when it comes to health issues, whether or not the results of searches are providing them with the best information on a regular basis.
Mounting interest in the field of mHealth—the provision of health-related services via mobile communica-tions—can be traced to the evolution of several interrelated trends. In many parts of the world, epidemicsand a shortage of healthcare workers continue to present grave challenges for governments and healthproviders. Yet in these same places, the explosive growth of mobile communications over the past decadeoffers a new hope for the promotion of quality healthcare. Among those who had previously been left behindby the ‘digital divide,’ billions now have access to reliable technology.There is a growing body of evidence that demonstrates the potential of mobile communications to radicallyimprove healthcare services—even in some of the most remote and resource-poor environments. This reportexamines issues at the heart of the rapidly evolving intersection of mobile phones and healthcare. It helps thereader to understand mHealth’s scope and implementation across developing regions, the health needs towhich mHealth can be applied, and the mHealth applications that promise the greatest impact on heath careinitiatives. It also examines building blocks required to make mHealth more widely available through sustain-able implementations. Finally, it calls for concerted action to help realize mHealth’s full potential.
April 2011 Study from WEGO Health focusing on how engaged and active Internet and social media users perceive pharma and health company use of the Internet
RememberItNow Presentation to U.S. Office of eHealth InitiativesMobile PRM
RememberItNow! recently presented their eHealth service to the U.S. Office of eHealth Initiatives in response to their request for information on new medication management technology.
Learn how RememberItNow! can improve medication compliance with SMS, Push and eMail medication reminders, an easy-to-use PHR, and a private care community.
Discover the future of eHealth and how it starts with the patient’s perspective. To learn more about RememberItNow! please visit:
http://www.rememberitnow.com
Healthcare Social Networking: Is Pharma Ready to Join the Conversation?Len Starnes
A pragmatic assessment of the impact of social networking on pharma marketing & sales. Includes analyses of HCPs' social networks, consumer/patient social networks and the convergence of PR with SEO and SEM. Presented at conferences in Zurich, Shanghai and Boston during 2008. This version presented at EyeforPharma's
E-Communications and Online Marketing Summit, Boston, 2008.
Just a year ago, Pew Internet & American Life Project report that nearly 113 million Americans were using the Internet to gather health-related information. It's not news that the Internet has become a magnet for people looking for quick answers when it comes to health issues, whether or not the results of searches are providing them with the best information on a regular basis.
DIA Marketing Pharmaceuticals 2015 Leveraging Innovative TechnologiesDale Cooke
This is the slide deck I used to introduce a session on how sponsors of prescription drugs, biologics, and medical devices can take advantage of the newer means that both consumers and healthcare professionals are using to access information, while remaining compliant with FDA regulations.
The thoughts of patients, health advocates, former government officials, bloggers and others who participated in a roundtable discussion that AstraZeneca convened in 2010.
Perficient Perspectives: The Evolution of Social Media in HealthcarePerficient, Inc.
Healthcare organizations continue to navigate the transforming healthcare industry and identify new avenues to engage with consumers outside of the facility walls. In a fast-paced, information-dominated world, successfully interacting with consumers may seem like a daunting task. The key is to connect with consumers where they are and provide them with actionable health and wellness information they need to live a healthier life.
When you think of social media in healthcare you might think it is a tool for marketing, but it goes much farther than that. Sure, social media can be used to attract and retain consumers, but social media can also be a powerful tool to reduce healthcare costs and help with chronic disease and population health management.
Healthcare organizations are in varying stages of becoming social enterprises, from social innovators like Mayo Clinic to those beginning the journey to developing a comprehensive social media strategy.
In this perspective, we take a look at the evolution of social media in healthcare and discuss what social media in healthcare will look like in the future.
Social Media Won't Wait: Health Activist Speak Out, Industry Speaks Up (WEGO ...WEGO Health
Expanded and annotated report of the survey presentation delivered by WEGO Health and a panel of pharmaceutical executives at the April 2011 DTC National Conference.
These slides provide an overview of a white paper - “Connecting with Patients, Overcoming Uncertainty” white paper was produced by Envision Solutions, TNS Media Intelligence/Cymfony and law firm Seyfarth Shaw.
Edelman Health Barometer 2008: Health Influence in the Era of Public Engagement
Edelman Health Barometer 2010 (http://www.slideshare.net/edelmaninc/edelman-health-engagement-barometer-2010)
Leveraging Social Media for Healthcare ProvidersGreenway Health
Eighty-one percent of Americans look for health information online- but from whom are they getting it? Social media gives providers the opportunity to influence the information their patients are reading online and to engage them in a meaningful conversation. Learn how to utilize these technologies to improve patient communication, outcomes and even your bottom line.
Companies can leverage social media to drive business and compete effectively in the new era of health care. But what do you need to know before jumping in or expanding your efforts? What considerations do medical technology marketing professionals need to take into account when implementing a strategic social-media plan?
Part one of our five-part series outlines how medical technology professionals can use social media in a regulated environment. Even more importantly, it gives readers the supporting evidence needed to recommend specific social-media strategies to management and internal legal and regulatory teams.
How to use the Power of Social Media in the Pharmaceutical Industry.pdfdnyaneshwarivedpatha1
Impact of COVID-19 on Social Media Engagement
The outbreak of the COVID-19 pandemic in 2020 brought about significant shifts in online behavior, particularly in the pharmaceutical sector. With national lockdowns and social distancing measures in place, people turned to social media as a primary source of information, entertainment, and connection. The average user spent more time than ever on social media platforms, seeking news updates, community support, and healthcare guidance.
Importance of Understanding Regulatory Landscape
Amidst this digital evolution, it’s crucial for pharmaceutical companies to navigate the regulatory landscape effectively while leveraging the power of social media. Regulations play a vital role in ensuring ethical practices, accuracy of information, and protection of consumers’ health and privacy. Therefore, understanding and adhering to regulatory guidelines is paramount for pharmaceutical organizations engaging in social media marketing.
This blog will delve into the intersection of social media marketing and regulatory compliance within the pharmaceutical industry, highlighting key guidelines, best practices, and the evolving landscape shaped by global trends and pandemic influences.
Evolution of FDA Regulations
Historical Restrictions on Pharmaceutical Content
In the early days of social media, pharmaceutical companies faced stringent restrictions on the type of content they could share online. The FDA’s regulatory framework, aimed at ensuring public safety and preventing misleading information, posed challenges for marketers in the pharmaceutical sector. Companies had to navigate complex rules regarding the promotion of prescription drugs, including limitations on discussing specific drug benefits and risks in online platforms.
Changing Landscape and Updated Regulations
Over time, the landscape of social media marketing in the pharmaceutical industry has evolved significantly. Regulatory bodies like the FDA have recognized the growing influence of digital platforms and the need for updated guidelines that strike a balance between promotional activities and regulatory compliance. This shift has led to the revision of regulations and the introduction of updated guidelines tailored to the digital era.
The FDA, in collaboration with industry stakeholders, has issued guidance documents and updates to help pharmaceutical companies navigate social media marketing responsibly. These guidelines address key areas such as fair balance in promotional content, disclosure of risk information, handling of adverse events, and engagement with online communities. The changing regulations reflect a broader acknowledgment of the importance of digital communication channels in healthcare information dissemination.
Importance of Compliance Amidst Evolving Regulations
Compliance with regulatory requirements is paramount for pharmaceutical companies operating in the social media landscape. As regulations evolve
Life science companies need to ensure their business initiatives take advantage of social media analytics. Read about the challenge of maximizing the opportunity and generating value from real world patient insights.
Case Study: Social Media - Getting Started in a Heavily Regulated Environment
Presented by: Gigi Peterkin, Associate Director of Interactive Media, AstraZeneca
From the national stage to living rooms on Main Street, healthcare is under a collective microscope – perhaps moreso now than at any other time in our history. With all eyes on the industry, is now the time to jump into social media or is it better to sit back and “ride it out”, waiting for the FDA to present a road map in the form of governance? Whatever your thoughts on timing, getting into the ‘social media game’ in a regulated industry presents a unique set of challenges and risks. From organizing internally to executing externally, I’ll share insights on how we got off the ground at AstraZeneca – and where we go from here.
www.bdionline.com
지난 2013년 6월 “Digital Health: Building Social Confidence in Pharma’라는 제목으로 웨버 샌드윅(Weber Shandwick)이 발표한 리포트는 현재 글로벌 제약회사에서 소셜 미디어 커뮤니케이션 활동을 책임지는 13명의 임원들과 마케팅 컨설턴트가 참여했으며, 제약회사들의 소셜 미디어 도입 현황, 도입 시 혜택, 극복과제, 실행 방안 등 주제별 주요 인사이트가 반영되어 있다.
HCS490 v11External Influences on Consumer Choice WorksheetHCSJeanmarieColbert3
HCS/490 v11
External Influences on Consumer Choice Worksheet
HCS/490 v11
Page 2 of 2
External Influences on Consumer Choice Worksheet
Health care consumers receive various communications about different health care options. It is important to understand consumer demographics to determine the impact (positive or negative) media, social networks, branding, marketing, and communication play in health care consumer choices.
In this assignment, you will research managed care plans to determine what impact social media and other external influences have on consumer behaviors. Research the different managed care insurance plans listed below by reviewing various health care organizations or resources (e.g., Kaiser as an HMO).
Consider within your research who might access the health care systems (i.e., age, generation, socioeconomic status, military/veteran, and health care insurance plans, etc.).
List 2 advantages and 2 disadvantages of HMOs, PPOs, and POSs in the following chart.
Health Maintenance Organization (HMO)
Preferred Provider Organization (PPO)
Point of Service (POS)
Advantages
1.
2.
1.
2.
1.
2.
Disadvantages
1.
2.
1.
2.
1.
2.
Write a 90- to 175-word response to the following prompts. Consider the information you listed in the chart above as well as what you know about consumer behavior when you compose your response.
· Explain the impact media and social networking have on consumers when choosing the most appropriate managed care health insurance plans. Consider the positive and negative impacts.
· Describe how branding, marketing, and communication influence a consumer’s choice when considering an appropriate managed care health insurance plan. Consider positive and negative influences.
· Explain how communication and education to consumers differ by generation when marketing managed care health insurance plans. Consider why it is important to communicate and educate differently across generations.
Cite 2 peer-reviewed, scholarly, or similar references.
Copyright 2021 by University of Phoenix. All rights reserved.
Copyright 2021 by University of Phoenix. All rights reserved.
7.2 Discussion Board: Effective Project Communication Topic 1
Topic 1: Documenting and Communicating Project Progress
One of the concepts discussed in Chapter 6 of the textbook “Strategic Project Management – BUS 5661” is the importance of documenting and communicating the progress on a project. Your company is a major software development company that develops enterprise software for Internet and mobile applications. You have recently been appointed the team leader on a new software development project. The members of your team have worked on various software development projects for the company. At your first team meeting, you suggest that the team meet every time the project reaches a major milestone, as defined in the project plan. However, several members of your team complained that the meetings are a waste of time. These members feel that a well-writte ...
Similar to WEGO Health FDA Post-Presentation Data (20)
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...kevinkariuki227
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
Title: Sense of Taste
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the structure and function of taste buds.
Describe the relationship between the taste threshold and taste index of common substances.
Explain the chemical basis and signal transduction of taste perception for each type of primary taste sensation.
Recognize different abnormalities of taste perception and their causes.
Key Topics:
Significance of Taste Sensation:
Differentiation between pleasant and harmful food
Influence on behavior
Selection of food based on metabolic needs
Receptors of Taste:
Taste buds on the tongue
Influence of sense of smell, texture of food, and pain stimulation (e.g., by pepper)
Primary and Secondary Taste Sensations:
Primary taste sensations: Sweet, Sour, Salty, Bitter, Umami
Chemical basis and signal transduction mechanisms for each taste
Taste Threshold and Index:
Taste threshold values for Sweet (sucrose), Salty (NaCl), Sour (HCl), and Bitter (Quinine)
Taste index relationship: Inversely proportional to taste threshold
Taste Blindness:
Inability to taste certain substances, particularly thiourea compounds
Example: Phenylthiocarbamide
Structure and Function of Taste Buds:
Composition: Epithelial cells, Sustentacular/Supporting cells, Taste cells, Basal cells
Features: Taste pores, Taste hairs/microvilli, and Taste nerve fibers
Location of Taste Buds:
Found in papillae of the tongue (Fungiform, Circumvallate, Foliate)
Also present on the palate, tonsillar pillars, epiglottis, and proximal esophagus
Mechanism of Taste Stimulation:
Interaction of taste substances with receptors on microvilli
Signal transduction pathways for Umami, Sweet, Bitter, Sour, and Salty tastes
Taste Sensitivity and Adaptation:
Decrease in sensitivity with age
Rapid adaptation of taste sensation
Role of Saliva in Taste:
Dissolution of tastants to reach receptors
Washing away the stimulus
Taste Preferences and Aversions:
Mechanisms behind taste preference and aversion
Influence of receptors and neural pathways
Impact of Sensory Nerve Damage:
Degeneration of taste buds if the sensory nerve fiber is cut
Abnormalities of Taste Detection:
Conditions: Ageusia, Hypogeusia, Dysgeusia (parageusia)
Causes: Nerve damage, neurological disorders, infections, poor oral hygiene, adverse drug effects, deficiencies, aging, tobacco use, altered neurotransmitter levels
Neurotransmitters and Taste Threshold:
Effects of serotonin (5-HT) and norepinephrine (NE) on taste sensitivity
Supertasters:
25% of the population with heightened sensitivity to taste, especially bitterness
Increased number of fungiform papillae
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journeygreendigital
Tom Selleck, an enduring figure in Hollywood. has captivated audiences for decades with his rugged charm, iconic moustache. and memorable roles in television and film. From his breakout role as Thomas Magnum in Magnum P.I. to his current portrayal of Frank Reagan in Blue Bloods. Selleck's career has spanned over 50 years. But beyond his professional achievements. fans have often been curious about Tom Selleck Health. especially as he has aged in the public eye.
Follow us on: Pinterest
Introduction
Many have been interested in Tom Selleck health. not only because of his enduring presence on screen but also because of the challenges. and lifestyle choices he has faced and made over the years. This article delves into the various aspects of Tom Selleck health. exploring his fitness regimen, diet, mental health. and the challenges he has encountered as he ages. We'll look at how he maintains his well-being. the health issues he has faced, and his approach to ageing .
Early Life and Career
Childhood and Athletic Beginnings
Tom Selleck was born on January 29, 1945, in Detroit, Michigan, and grew up in Sherman Oaks, California. From an early age, he was involved in sports, particularly basketball. which played a significant role in his physical development. His athletic pursuits continued into college. where he attended the University of Southern California (USC) on a basketball scholarship. This early involvement in sports laid a strong foundation for his physical health and disciplined lifestyle.
Transition to Acting
Selleck's transition from an athlete to an actor came with its physical demands. His first significant role in "Magnum P.I." required him to perform various stunts and maintain a fit appearance. This role, which he played from 1980 to 1988. necessitated a rigorous fitness routine to meet the show's demands. setting the stage for his long-term commitment to health and wellness.
Fitness Regimen
Workout Routine
Tom Selleck health and fitness regimen has evolved. adapting to his changing roles and age. During his "Magnum, P.I." days. Selleck's workouts were intense and focused on building and maintaining muscle mass. His routine included weightlifting, cardiovascular exercises. and specific training for the stunts he performed on the show.
Selleck adjusted his fitness routine as he aged to suit his body's needs. Today, his workouts focus on maintaining flexibility, strength, and cardiovascular health. He incorporates low-impact exercises such as swimming, walking, and light weightlifting. This balanced approach helps him stay fit without putting undue strain on his joints and muscles.
Importance of Flexibility and Mobility
In recent years, Selleck has emphasized the importance of flexibility and mobility in his fitness regimen. Understanding the natural decline in muscle mass and joint flexibility with age. he includes stretching and yoga in his routine. These practices help prevent injuries, improve posture, and maintain mobilit
Title: Sense of Smell
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the primary categories of smells and the concept of odor blindness.
Explain the structure and location of the olfactory membrane and mucosa, including the types and roles of cells involved in olfaction.
Describe the pathway and mechanisms of olfactory signal transmission from the olfactory receptors to the brain.
Illustrate the biochemical cascade triggered by odorant binding to olfactory receptors, including the role of G-proteins and second messengers in generating an action potential.
Identify different types of olfactory disorders such as anosmia, hyposmia, hyperosmia, and dysosmia, including their potential causes.
Key Topics:
Olfactory Genes:
3% of the human genome accounts for olfactory genes.
400 genes for odorant receptors.
Olfactory Membrane:
Located in the superior part of the nasal cavity.
Medially: Folds downward along the superior septum.
Laterally: Folds over the superior turbinate and upper surface of the middle turbinate.
Total surface area: 5-10 square centimeters.
Olfactory Mucosa:
Olfactory Cells: Bipolar nerve cells derived from the CNS (100 million), with 4-25 olfactory cilia per cell.
Sustentacular Cells: Produce mucus and maintain ionic and molecular environment.
Basal Cells: Replace worn-out olfactory cells with an average lifespan of 1-2 months.
Bowman’s Gland: Secretes mucus.
Stimulation of Olfactory Cells:
Odorant dissolves in mucus and attaches to receptors on olfactory cilia.
Involves a cascade effect through G-proteins and second messengers, leading to depolarization and action potential generation in the olfactory nerve.
Quality of a Good Odorant:
Small (3-20 Carbon atoms), volatile, water-soluble, and lipid-soluble.
Facilitated by odorant-binding proteins in mucus.
Membrane Potential and Action Potential:
Resting membrane potential: -55mV.
Action potential frequency in the olfactory nerve increases with odorant strength.
Adaptation Towards the Sense of Smell:
Rapid adaptation within the first second, with further slow adaptation.
Psychological adaptation greater than receptor adaptation, involving feedback inhibition from the central nervous system.
Primary Sensations of Smell:
Camphoraceous, Musky, Floral, Pepperminty, Ethereal, Pungent, Putrid.
Odor Detection Threshold:
Examples: Hydrogen sulfide (0.0005 ppm), Methyl-mercaptan (0.002 ppm).
Some toxic substances are odorless at lethal concentrations.
Characteristics of Smell:
Odor blindness for single substances due to lack of appropriate receptor protein.
Behavioral and emotional influences of smell.
Transmission of Olfactory Signals:
From olfactory cells to glomeruli in the olfactory bulb, involving lateral inhibition.
Primitive, less old, and new olfactory systems with different path
Basavarajeeyam is an important text for ayurvedic physician belonging to andhra pradehs. It is a popular compendium in various parts of our country as well as in andhra pradesh. The content of the text was presented in sanskrit and telugu language (Bilingual). One of the most famous book in ayurvedic pharmaceutics and therapeutics. This book contains 25 chapters called as prakaranas. Many rasaoushadis were explained, pioneer of dhatu druti, nadi pareeksha, mutra pareeksha etc. Belongs to the period of 15-16 century. New diseases like upadamsha, phiranga rogas are explained.
Explore natural remedies for syphilis treatment in Singapore. Discover alternative therapies, herbal remedies, and lifestyle changes that may complement conventional treatments. Learn about holistic approaches to managing syphilis symptoms and supporting overall health.
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdfAnujkumaranit
Artificial intelligence (AI) refers to the simulation of human intelligence processes by machines, especially computer systems. It encompasses tasks such as learning, reasoning, problem-solving, perception, and language understanding. AI technologies are revolutionizing various fields, from healthcare to finance, by enabling machines to perform tasks that typically require human intelligence.
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...GL Anaacs
Contact us if you are interested:
Email / Skype : kefaya1771@gmail.com
Threema: PXHY5PDH
New BATCH Ku !!! MUCH IN DEMAND FAST SALE EVERY BATCH HAPPY GOOD EFFECT BIG BATCH !
Contact me on Threema or skype to start big business!!
Hot-sale products:
NEW HOT EUTYLONE WHITE CRYSTAL!!
5cl-adba precursor (semi finished )
5cl-adba raw materials
ADBB precursor (semi finished )
ADBB raw materials
APVP powder
5fadb/4f-adb
Jwh018 / Jwh210
Eutylone crystal
Protonitazene (hydrochloride) CAS: 119276-01-6
Flubrotizolam CAS: 57801-95-3
Metonitazene CAS: 14680-51-4
Payment terms: Western Union,MoneyGram,Bitcoin or USDT.
Deliver Time: Usually 7-15days
Shipping method: FedEx, TNT, DHL,UPS etc.Our deliveries are 100% safe, fast, reliable and discreet.
Samples will be sent for your evaluation!If you are interested in, please contact me, let's talk details.
We specializes in exporting high quality Research chemical, medical intermediate, Pharmaceutical chemicals and so on. Products are exported to USA, Canada, France, Korea, Japan,Russia, Southeast Asia and other countries.
micro teaching on communication m.sc nursing.pdfAnurag Sharma
Microteaching is a unique model of practice teaching. It is a viable instrument for the. desired change in the teaching behavior or the behavior potential which, in specified types of real. classroom situations, tends to facilitate the achievement of specified types of objectives.
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists Saeid Safari
Preoperative Management of Patients on GLP-1 Receptor Agonists like Ozempic and Semiglutide
ASA GUIDELINE
NYSORA Guideline
2 Case Reports of Gastric Ultrasound
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
WEGO Health FDA Post-Presentation Data
1.
2.
3. Influence WEGO Health Activist Ellen Audience of ~50,000 people per month Featured blogger for Invisible Illness Week Active member of Yahoo! Migraine Group Featured in Headache Blog Carnival Active member of care4dystonia.org Active member of BioMedCentral Active member of CafeMom WEGO Health Activists Are Social Media Power Users WEGO Health Activists are most often active several times per day, on multiple social media sites and communities.
4. “ Companies are largely missing from the supportive, real-life conversations going on in health discussion groups, on social networks, and such… I’ve been at this long enough to know they have regulations that get in the way, but everyone would benefit if (companies) could be at the table with us…” --- Ellen, WEGO Health Activist WEGO Health conducted a survey of over 160 Health Activists like Ellen, health social media leaders, to ask their opinions on the questions FDA addressed in these hearings. Their comments – like this one – will help bring to life our survey findings.
5.
6. Social media is an important tool for health communication Each key point of our findings is explored and illustrated in the following slides.
7. How useful are each of these social media tools in helping people to understand important health issues? Health Activists clearly value social media tools, especially those that offer real opportunity for interaction, and dedicated health sites. Discussion Forums and Message Boards Dedicated Health Social Networks Social Media “Coverage of Health Events Blogs Q & A Site General Social Networks
8. “ It’s the people who seem to be the most interested in the topics and have done the most personal research and will tell personal stories…that’s what discussion forums are filled with… I think they’re wonderful, and you get such a variety of information…” --- Bill, WEGO Health Activist Strategic Implication: FDA and Health Care Companies must embrace social media to communicate effectively with consumers
10. Does the use of social media by Health Care Companies help people to understand important health issues? brings accurate information into conversations about drugs or devices provides important updates on products or services addresses frequently asked questions about products or services adds valuable professional expertise to the conversation AGREE Health Care Companies’ use of social media tools… A strong majority of Health Activists appreciate the expertise that companies could bring to social media conversations – they understand the context of company participation and expect full transparency.
11. How should Health Care Companies disclose their participation in social media sites? And transparency, in the eyes of Health Activists, should be clear and visible. Most favored Company links, logos or other indicators – and felt third parties acting for the Company should be held to the same standards.
12. “ I kind of see (company participation) as a little biased, but I do like it when you have a forum going on - and actual drug facts, what it’s used for, what the side effects are - when a company brings that into the picture, that’s excellent, either by providing links or listing everything right there…” --- David, WEGO Health Activist Strategic Implication: Health Care Companies should participate in social media - IF they bring valuable information
13. Health Care Companies have an obligation to correct misinformation about their products While Health Activists do welcome industry involvement in their communities, they also feel that companies have obligations to be stewards of their products.
14. How should Health Care Companies get involved in monitoring and correcting misconceptions or misinformation about their products on other Web sites beyond their control? AGREE Health Care Companies… Almost all agreed Companies should get involved when the information may be harmful to people using the product, or when the Company feels it has information helpful to the community. Health Activists do have high expectations – 63% agreed Companies should get involved in monitoring and correcting misinformation about their product anywhere on the Internet.
15. “ The Allergan corporation jumped on our Dystonia forum, it was surprising, because we were talking about Botox and marketing, basically complaining about it, and they came onto the site and left a comment about it, and it was good. It made it seem like we aren’t just yelling into the air, someone actually is paying attention to what we’re saying and our concerns, and listening. And it seemed like they couldn’t say much, but they said enough to say, ‘we are listening to what you are saying, and we care.’” --- Jennifer, WEGO Health Activist Strategic Implication: Health Activists welcome fully transparent corrections by companies – and trust companies who make the effort
16. Online content …can be altered from its original state by people who don’t work for the company Agree Health Care Companies should be responsible for policing any unauthorized versions of their content 64% “ Online content created by Health Care Companies, and regulated by the FDA, can be altered from its original state by people who don’t work for the company. This unauthorized, altered content can be posted or distributed. Indicate your perspective.” While they favor Company policing, Health Activists acknowledge that monitoring the entire Internet is an impossible expectation. Agree Health Care Companies cannot reasonably keep up with the monitoring of all mentions of their content 60%
17. “ It’s paradoxical, really. It’s a good thing if (companies) could do it, but I can’t imagine how they could be everywhere. It’s sort of unreasonable. I would tell them to hire people for that purpose. It’s important, it’s just important.” --- Debra, WEGO Health Activist Strategic Implication: Health Care Companies must monitor proactively, while FDA – and Health Activists – need to define “best effort”
19. When do you feel a Health Care Company’s participation in Internet and social media technologies should be regulated? When Health Care Companies… Health Activists agree strongly that Companies should be regulated when they pay for or sponsor content. Comments, however, were seen as the domain of the consumer, and fewer Health Activists felt comments should be regulated.
20. “ Health Care Companies have the most direct information about their own studies that they’ve conducted and their products, and we’ll lose that whole side of the conversation… I think we need to balance that conversation with the negative perception of Health Care Companies . They should have their opportunity to present their side as well, we should have a real dialogue.” --- Lauren, WEGO Health Activist Strategic Implication: Health Activists want regulation – but not at the expense of Health Care Companies’ participation
21. Regulation of Health Care Companies in social media is challenging, and the FDA should work to tailor regulations to the practical realities of social media
22. What are appropriate ways for Health Care Companies to fulfill regulatory requirements in their Internet and social media activities…? “ What are appropriate ways for Health Care Companies to fulfill regulatory requirements in their Internet and social media activities, particularly when using tools that are associated with space limitations and tools that allow for real-time communications (e.g., micro-blogging platforms like Twitter, and mobile technology)?” ...should be required to make all regulatory-required information available one click away from their social media communications ...participating in social media should include a link to their product website in every communication ...should be allowed to present a shorter version of regulatory-required information when social media tools do not allow adequate space ...using real-time communications should be required to restate regulatory-required information in all their messages ...should not be allowed to participate in Internet and social media tools that don’t allow space for regulatory-required information ...should not be required to include regulatory-required information on social media platforms that cannot accommodate it AGREE Health Care Companies… NOTE: Fully visible data from this slide follows this annotated slide. Health Activists voted strongly for a solution: nearly 72% wanted regulatory-required information available one click away from Company social media communications; 71% want companies to include a link to their product website in every social media communication. Less than 18% were willing to say Companies need not be required to include regulatory-required information on social media platforms that cannot accommodate it. Fewer Health Activists felt comments should be regulated.
23. What are appropriate ways for Health Care Companies to fulfill regulatory requirements in their Internet and social media activities…? “ What are appropriate ways for Health Care Companies to fulfill regulatory requirements in their Internet and social media activities, particularly when using tools that are associated with space limitations and tools that allow for real-time communications (e.g., micro-blogging platforms like Twitter, and mobile technology)?” ...should be required to make all regulatory-required information available one click away from their social media communications ...participating in social media should include a link to their product website in every communication ...should be allowed to present a shorter version of regulatory-required information when social media tools do not allow adequate space ...using real-time communications should be required to restate regulatory-required information in all their messages ...should not be allowed to participate in Internet and social media tools that don’t allow space for regulatory-required information ...should not be required to include regulatory-required information on social media platforms that cannot accommodate it AGREE Health Care Companies…
24. “ On Hulu(.com), they do the Yaz commercial. So they do the one-click away link, and they do the regulation thing in the end of the video. I don’t want to watch the last two minutes of this video with all the side effects to Yaz. But if you click anywhere on the screen it takes you to the Yaz website, it’s more information than if you talk to your doctor about it. It’s very thorough, I guess all within the FDA guidelines, and they’re covering everything you could probably think of from that video…” --- Jennifer, WEGO Health Activist Strategic Implication: Health Activists support fair balance – if it’s presented in a way that’s tailored to the online experience
25. Agree regulation of Health Care Companies’ participation in Internet and social media needs to be tailored to the unique attributes of the Internet and social media 74% How do you feel about regulation of Health Care Companies’ participation in Internet and social media? WEGO Health Activists are passionate about the power of health social media – they see it as a powerful, new way to level the playing field for Companies and Consumers, and they understand the FDA’s challenge. Agree open Internet and social media conversation between Health Care Companies and people online is valuable, and regulations should not prevent those open conversations 64%
26. “ It’s not like somebody has the upper hand, as it is in the case of TV advertising, where only companies with lots and lots of money get their voice heard on TV…people don’t have to have money and that kind of influence to be able to become a voice that is listened to in social media and the online world. Which means there are a lot more voices and things are going to get debated, which hasn’t been the case in the kinds of media that the FDA is used to.” --- Megan, WEGO Health Activist Strategic Implication: Let’s work together – FDA, Health Care Companies and Health Activists – to develop guidance that works for us all
27. Companies, web sites and the FDA should monitor for Adverse Events, and provide simple means of reporting
28. “ As to the issue of how much (companies) can monitor misinformation or monitor what’s being said about their product… they can devote resources to have people whose job is to monitor the Internet, find out what’s being said, and see what the appropriate response is. We’re not talking about you or me, we’re talking about companies that are big enough and wealthy enough to make sure that what’s out there is accurate.” --- Megan, WEGO Health Activist The WEGO Health survey tool defined adverse events for Health Activists, including the four criteria for a reportable adverse event, as context for this section.
29. Keeping in mind the 4 elements that must be present…how often do you feel you see reportable adverse events online? 36% “sometimes” or “often” Only 36% of Health Activists saw AE’s “sometimes”, which means once a month, or “often”, which means once a week. Keeping in mind that these are hyper-active online WEGO Health opinion leaders, they are most likely to encounter adverse events.
30. Are you aware of a way for patients to report adverse events directly to the FDA? 52% “no” Only about half of Health Activists were aware of direct-to-FDA reporting.
31. Do you feel Health Care Companies should actively monitor online conversations to seek possible adverse events? 51% “yes” 51% did feel that Health Care Companies should actively monitor online conversations to seek possible AEs – but 49% did not want Company monitoring, or just didn’t know. Health Activists truly are of two minds on the topic of AE monitoring.
32. AGREE: Health Care Companies should respect that person’s anonymity and no report should be required 48% If a Health Care Company cannot identify the “patient” describing an adverse event online, what should the company do? The source of concern is the definition of monitoring – and where it begins to overrun privacy. DISAGREE: Health Care Companies should make every available effort to contact that person, using all available avenues to find contact information (e.g., querying ISPs to request the person’s email address) 47%
33. If a Health Care Company cannot identify the “patient” describing an adverse event online, what should the company do? Health Care Companies should encourage social media sites with health areas to post a clear, persistent link to an online form for reporting adverse events An identified Health Care Company representative should post a link (e.g., in a comment or a wall post or a tweet) to an online form for reporting the adverse event Health Care Companies should make their best effort to contact that person using the tools available within the social media platform where the adverse event was described (e.g., by sending a private message, by commenting on a blog post) Health Care Companies should make their best effort to contact that person using other tools to find contact information (e.g., searching for contact information associated with that person’s screen name) WEGO Health Activists support efforts to find AE reporters in social media, but only when those efforts preserve privacy – by communicating with an unidentified reporter only through the site where the AE was originally identified.
34. “ Contacting them thru the same platform they posted the info on is one thing, but starting to Google search them, trying to track down their contact information…people could feel very violated, especially since people use screen names online to protect their anonymity…” --- Lauren, WEGO Health Activist Strategic Implication: Health Activists expect vigilance on adverse events – but within the boundaries of online convention, and not at the expense of privacy It’s WEGO Health’s belief that the first companies to proactively seek AEs – to reach out to consumers on their terms, respectful of privacy – will be rewarded with appreciation and trust by the online community.
35. For more information about the WEGO Health Activist Social Media Survey or the WEGO Health Activist Network: www.wegohealth.com/socialmediasurvey [email_address]